News

Stimulating Interactions

NEWS

LogicInk – Is the future of wearable health tech ….TATTOOS?

Is the future of wearable health tech ….TATTOOS? A Talk at Techonomy On November 9th 2016, LogicInk gave their first public talk as a company at a conference called Techonomy in Half Moon Bay, CA. What happens when low-cost biosensors embedded in tattoos can detect blood alcohol, sugar, or biomarkers related to diseases like malaria or zika? How will that […]

Read more

Nucleo Life Sciences

Nucleo Life Sciences will be expanding their team to broaden the number of formulation and drug development projects they are tackling. Borne out of Actera, another former QB3@953 company, Nucleo Life Sciences incubated with us for a little over one year before outgrowing our location.

Read more

Perlara PBC Announces Pharma Collaboration with Novartis

Perlara PBC Announces Pharma Collaboration with Novartis SAN FRANCISCO, Oct. 19, 2016 /PRNewswire/ Perlara PBC (previously Perlstein Lab PBC) today announced the formation of a drug discovery and development collaboration with Novartis to identify new definitive therapeutics for lysosomal storage disorders, starting with lead program Niemann-Pick Type C Disease. In addition to the collaboration, Novartis has made an equity investment […]

Read more

Amgen Incubators Grow Startup for Harvest

Amgen Incubators Grow Startup for Harvest Venture division seeks access to technology, potential takeovers. San Fernando Valley Business Journal, July 11-24, 2016 By STEPHANIE HENKEL, Staff Reporter Amgen inc. hopes to get in on more ground floors by sponsoring startups in the biotech hubs in Cambridge, Mass. and, more recently, in San Francisco. The Thousand Oaks biopharmaceutical company last month […]

Read more

Kite Pharma and Cell Design Labs Announce Exclusive Research Collaboration

Kite Pharma and Cell Design Labs Announce Exclusive Research Collaboration Using Molecular ‘On/Off Switches’ for CAR T-Cell Immunotherapies Kite to License Cell Design Labs’ Synthetic Biology Technology for Applications in Acute Myeloid Leukemia with Exclusive Option for Applications in B-cell Malignancies Cell Design Labs’ Reversible ‘On/Off Switch’ Technology Provides Dynamic Range of Control to Precisely Regulate Activity of Engineered CAR […]

Read more

Cell Design Labs Executes Series of Private Financings

Cell Design Labs Executes Series of Private Financings New Company Focused on Discovering and Developing Next-Generation Immunotherapies for Cancer and Other Complex Diseases   SAN FRANCISCO, Calif. June 2, 2016 — Cell Design Labs, Inc. today announced it has executed a staged series of investor and strategic partner financings totaling $34.4 million to fund the company’s start-up operations. The investors, […]

Read more

Avant Completes Acquisitions of Amarantus, Theranostics Health

Avant Completes Acquisitions of Amarantus and Theranostics Health Avant Diagnostics announced today that it has completed its previously announced acquisitions of Amarantus Diagnostics and protein analysis services provider Theranostics Health. In January, Scottsdale, Arizona-based Avant inked a deal to merge with Amarantus Diagnostics, a subsidiary of therapeutics developer Amarantus Bioscience. The arrangement joins Amarantus’ research-use-only assays for multiple sclerosis and […]

Read more

ViewPoint Therapeutics Raises $4 Million in Series A Financing

ViewPoint Therapeutics Raises $4 Million in Series A Financing ViewPoint Therapeutics, Inc., a privately-held biotechnology company pioneering the development of crystallin stabilizers to prevent and treat cataracts and presbyopia, today announced the closing of a $4 million Series A financing. The transaction was co-led by Mission Bay Capital and Lagunita BioSciences LLC. Also included in the syndicate was healthcare-dedicated investor, […]

Read more

Miroculus Acquires Microfluidics Firm Kapplex

MicroRNA Diagnostics Developer Miroculus Acquires Microfluidics Firm Kapplex Miroculus, a San Francisco startup developing microRNA-based diagnostic tests, said Monday that it has acquired Toronto-based microfluidics firm Kapplex for an undisclosed amount. Miroculus emerged from stealth mode earlier this year at Cambridge Healthtech Institute’s Molecular Medicine Tri-Conference. It aims to tap into the growing evidence that miRNAs can serve as useful […]

Read more

Dow AgroSciences and TeselaGen to collaborate

A new collaboration between Dow AgroSciences and TeselaGen Biotechnology Inc. is designed to produce a biological design automation platform that can speed up discovery work for new agricultural products. “TeselaGen has created a powerful suite of tools for DNA design,” said Daniel R. Kittle, Ph.D., vice president, research and development, Dow AgroSciences. “These tools have the potential to accelerate our […]

Read more
Page 2 of 712345...Last »

Address

953 Indiana St.
San Francisco, CA 94107
Tel: (415)-347-8287

Sign-Up for our Newsletter